Breaking News
Get 40% Off 0
🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since March See the stock
Close

GSK plc (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,746.50 +6.50    +0.37%
- Closed. Currency in GBP ( Disclaimer )
  • Volume: 8,397,352
  • Bid/Ask: 1,700.00 / 1,800.00
  • Day's Range: 1,729.00 - 1,746.50
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BN7SWP63 
SEDOL:  BN7SWP6
GSK plc 1,746.50 +6.50 +0.37%

LON:GSK Financials

 
This summary provides an overview of the most significant critical numbers from each of the Glaxo financial reports, including theGSK plc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the LON:GSK financials over time via breakdowns of their annual reports.

GSK plc reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was GBP 7,363 million compared to GBP 6,951 million a year ago. Net income was GBP 1,046 million compared to GBP 1,490 million a year ago. Basic earnings per share from continuing operations was GBP 0.257 compared to GBP 0.368 a year ago. Diluted earnings per share from continuing operations was GBP 0.254 compared to GBP 0.365 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GSK Income Statement & Profits

Gross margin TTM 72.67%
Operating margin TTM 28.39%
Net Profit margin TTM 14.59%
Return on Investment TTM 25.12%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 7363 8052 8147 7178
Gross Profit 5448 5237 5904 5279
Operating Income 2247 1639 2556 2051
Net Income 1046 350 1464 1624

GSK Balance Sheet

Quick Ratio MRQ 0.55
Current Ratio MRQ 0.87
LT Debt to Equity MRQ 109.51%
Total Debt to Equity MRQ 128.41%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 58511 59005 60862 59461
Total Liabilities 45282 46210 48243 47302
Total Equity 13229 12795 12619 12159

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 1.88
Revenue/Share TTM 7.52
Operating Cash Flow  4.83%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 958 3196 2212 1307
Cash From Investing Activities -149 268 -491 -964
Cash From Financing Activities -1060 -3592 -1762 31
Net Change in Cash -270 -162 -18 317
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Price Commentary

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it exceed 1800 and stay their is the question
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
more enough 5 year high. now will it smash through that high is the question.....
Reshad Chesson
Reshad Chesson Jan 31, 2024 13:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nov 1 call coming correct
Pavel Marchenko
Pavel Marchenko Jan 10, 2024 8:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks
Reshad Chesson
Reshad Chesson Jan 09, 2024 15:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did anyone act on my call.
Reshad Chesson
Reshad Chesson Nov 01, 2023 16:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
triple buy. tgt 1900
John Ford
John Ford Jan 24, 2023 15:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All export earners today are going south
Dan Morris
Dan Morris Dec 07, 2022 13:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
איציק צארלי
איציק צארלי Nov 28, 2022 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ITH stock
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought back all the gsk that I sold back in May. It's a no brainer at this price
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying GSK is like investing in a junk bond. One need to buy when the yield is high
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
. Well, yield is OK as long as it's not offset by value destruction through capital loss. In GSKs case as long as Walmsley is at the helm you can guarantee value destruction. She couldn't develop a blockbuster drug or vaccine if her life depended on it. Pascal Sorrel at Astra Zenrcca must be laughing his head off at this train crash of a CEO
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
John Hamilton
John Hamilton Nov 11, 2022 12:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new management required
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email